Denise Toscani

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study.

Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study.

Journal: Annals of hematology

Published: March 11, 2026

PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

Journal: Cancer gene therapy

Published: November 27, 2025

Oncolytic bovine herpesvirus type 1 induces immune microenvironment remodeling and enhances treatment responses in multiple myeloma.

Oncolytic bovine herpesvirus type 1 induces immune microenvironment remodeling and enhances treatment responses in multiple myeloma.

Journal: Haematologica

Published: September 30, 2025

A metabolic trade-off between malignant plasma cells and mesenchymal stromal cells sustains multiple myeloma growth.

A metabolic trade-off between malignant plasma cells and mesenchymal stromal cells sustains multiple myeloma growth.

Journal: Blood neoplasia

Published: April 08, 2025

Mechanistic insights into bone destruction in multiple myeloma: Cellular and molecular perspectives.

Mechanistic insights into bone destruction in multiple myeloma: Cellular and molecular perspectives.

Journal: Journal of bone oncology

Published: January 28, 2025

High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease.

High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease.

Journal: Leukemia

Published: January 28, 2025

Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients.

Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients.

Journal: Frontiers in immunology

Published: November 22, 2024

Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.

Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.

Journal: Haematologica

Published: March 24, 2023

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease.

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease.

Journal: International journal of molecular sciences

Published: January 27, 2023

The impact of CD56 expression in smoldering myeloma patients on early progression.

The impact of CD56 expression in smoldering myeloma patients on early progression.

Journal: Hematological oncology

Published: November 28, 2022

Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma.

Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma.

Journal: International journal of molecular sciences

Published: November 11, 2022

Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.

Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.

Journal: Oncoimmunology

Published: September 15, 2022

Showing 1-12 of 48

Last Updated: 09/26/2026